Showing results (101-110 of 281) with videos related to
Sort By:
Pageof 29
Leukemia|April 7, 1998
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemiaM V Relling, Y Yanishevski, J Nemec, et al.Pediatric Clinics of North America|October 1, 1989
Clinical pharmacology of cancer chemotherapy in childrenW E Evans, W P Petros, M V Relling, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Patient characteristics associated with high-risk methotrexate concentrations and toxicityM V Relling, D Fairclough, D Ayers, et al.Journal of Molecular Evolution|March 7, 2001
The geographic distribution of monoamine oxidase haplotypes supports a bottleneck during the dispersion of modern humans from AfricaJ Balciuniene, A C Syvänen, H L McLeod, et al.The Journal of Clinical Investigation|August 1, 1996
Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicityX Wei, H L McLeod, J McMurrough, et al.Leukemia|April 2, 2004
Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemiaL J Hak, M V Relling, C Cheng, et al.Pharmacotherapy|January 1, 1992
Variability in teniposide plasma protein binding is correlated with serum albumin concentrationsW P Petros, J H Rodman, M V Relling, et al.The Journal of Pediatrics|April 1, 1989
Lorazepam pharmacodynamics and pharmacokinetics in childrenM V Relling, R K Mulhern, R K Dodge, et al.Blood|July 15, 1994
Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemiaJ C Barredo, T W Synold, J Laver, et al.Leukemia|January 1, 1996
Allopurinol inhibits de novo purine synthesis in lymphoblasts of children with acute lymphoblastic leukemiaE Masson, T W Synold, M V Relling, et al.Pageof 29